Please assess the completion status of the following clinical trial:

Trial Title: Pharmacist Intervention for Glycemic Control in The Community

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or Female over 18 years of age~* Type 2 diabetes for at least 6 months~* Taking 1 or more oral hypoglycemic agents~* Patient attending your community pharmacy where you decided that addition of insulin glargine may be of benefit to the patient~* Baseline HbA1c 7.5 - 11%~* Signed informed consent~Exclusion Criteria:~* Have used, or currently using, Insulin~* History of ketoacidosis~* Pregnant~* Works night shift~* Renal impairment(Serum Creatinine: females ≥ 124 mmol/l, males ≥ 133 mmol/l)~* Clinically unstable~* Unwilling/unable to attend follow up visits~* Unlikely to adhere to study procedures (eg. due to cognitive limitations, severe psychiatric disorder or alcoholism)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Insulin glargine (Type: OTHER): 10 units at bedtime of insulin glargine will be prescribed to the patients who has HbA1c levels of 7.5-11%. Insulin glargine dose is going to be titrated by increments of 1 unit daily by the patient to achieve a morning fasting glucose of \<=5.5mmol/L

Based on this trial design, predict the completion outcome and termination type (if applicable).